Novo Nordisk said participants who took the once-daily pill in a clinical trial lost an average 16% of their body weight.

As the new Chief Wellness Amassador at Noom, a weight loss platform, Rebel Wilson is endorsing their GLP-1 'microdosing' ...

Higher doses of weight loss medications like Ozempic and Wegovy could help treat obesity. In two new studies, people taking 7 ...

Plus, solar cars, Meta’s new glasses and AI financial agents, in this edition of The Future of Everything newsletter.

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

A large clinical trial found that a daily semaglutide pill produced significant weight loss and health benefits comparable to injectable versions, setting the stage for possible FDA approval later ...

The GLP-1 boom is making people desperate to get the pricey weight-loss drugs. They won't get the real medication in "GLP-1 patches," doctors warn.

The drug. orforglipron, works on the same receptor as semaglutide (Ozempic/Wegovy), but can be taken without restrictions on food or water intake.

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

GLP-1 medications like Ozempic and Wegovy are helping people lose significant amounts of weight. But experts warn… they are ...

Over nearly six to ten years, individuals with obesity and type 2 diabetes who had metabolic (bariatric) surgery showed ...

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...